Hyper-IgM Immunodeficiency Syndrome, Type 1
"Hyper-IgM Immunodeficiency Syndrome, Type 1" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An X-linked hyper-IgM immunodeficiency subtype resulting from mutation in the gene encoding CD40 LIGAND.
MeSH Number(s)
C15.378.147.333.249.500
C16.320.322.237
C20.673.430.249.500
Concept/Terms
Hyper-IgM Immunodeficiency Syndrome, Type 1- Hyper-IgM Immunodeficiency Syndrome, Type 1
- Hyper IgM Immunodeficiency Syndrome, Type 1
- Hyper-IgM Immunodeficiency, X-Linked
- Hyper IgM Immunodeficiency, X Linked
- Hyper-IgM Immunodeficiencies, X-Linked
- Immunodeficiencies, X-Linked Hyper-IgM
- Immunodeficiency, X-Linked Hyper-IgM
- X-Linked Hyper-IgM Immunodeficiencies
- X-Linked Hyper-IgM Immunodeficiency
- Hyper-IgM Syndrome 1
- Hyper IgM Syndrome 1
- Syndrome 1, Hyper-IgM
- HIGM1 Syndrome
- HIGM1 Syndromes
- Syndrome, HIGM1
- Syndromes, HIGM1
Below are MeSH descriptors whose meaning is more general than "Hyper-IgM Immunodeficiency Syndrome, Type 1".
Below are MeSH descriptors whose meaning is more specific than "Hyper-IgM Immunodeficiency Syndrome, Type 1".
This graph shows the total number of publications written about "Hyper-IgM Immunodeficiency Syndrome, Type 1" by people in Harvard Catalyst Profiles by year, and whether "Hyper-IgM Immunodeficiency Syndrome, Type 1" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2018 | 1 | 0 | 1 |
| 2021 | 1 | 0 | 1 |
| 2022 | 1 | 0 | 1 |
Below are the most recent publications written about "Hyper-IgM Immunodeficiency Syndrome, Type 1" by people in Profiles.
-
Variants Disrupting CD40L Transmembrane Domain and Atypical X-Linked Hyper-IgM Syndrome: A Case Report With Leishmaniasis and Review of the Literature. Front Immunol. 2022; 13:840767.
-
Modeling, optimization, and comparable efficacy of T cell and hematopoietic stem cell gene editing for treating hyper-IgM syndrome. EMBO Mol Med. 2021 03 05; 13(3):e13545.
-
50 Years Ago in The Journal of Pediatrics: Familial Granulocytopenia and Associated Immunoglobulin Abnormality: Report of 3 Cases in Young Brothers. J Pediatr. 2018 03; 194:39.